MeSH D014328 - trophoblastic neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Accord Healthcare | Etoposide | Etoposide |  | 1996-03-14 |  |  |
| Allergan | Etoposide | Etoposide |  | 1996-10-15 |  |  |
| Bristol Myers Squibb | Etoposide | Etopophos |  | 1998-02-27 |  |  |
| CHEPLAPHARM Arzneimittel | Etoposide | Etopophos |  | 1996-05-17 |  |  |
| CordenPharma | Etoposide | Vepesid |  | 1983-11-10 |  |  |
| DASH Pharmaceuticals | Etoposide | Etoposide |  | 2017-11-20 |  |  |
| Fresenius Kabi | Etoposide | Etoposide |  | 1998-09-30 |  |  |
| Hikma Pharmaceuticals | Etoposide | Etoposide |  | 1995-07-17 |  |  |
| Hospira | Etoposide | Etoposide |  | 1995-08-30 |  |  |
| Laboratoires Pierre Fabre | Etoposide | Etoposide |  | 1997-07-09 |  |  |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
67%2/3
Phase 2
4%1/26
Phase 3
9%1/11
Approved: 1Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use